{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:40:16Z","timestamp":1793814016595,"version":"4.6.1"},"reference-count":140,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001674","name":"Leducq Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaccao.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:28:58Z","timestamp":1785983338000},"page":"449-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune Pathways in Doxorubicin Cardiotoxicity: A Cardio-Immunology Perspective"],"prefix":"10.1016","volume":"8","author":[{"given":"Giulia","family":"Guerra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2026.06.008_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaccao.2026.06.008_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib3","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jaccao.2026.06.008_bib4","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2026.06.008_bib5","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","article-title":"Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association","volume":"137","author":"Mehta","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.06.008_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib7","doi-asserted-by":"crossref","first-page":"e926","DOI":"10.1161\/CIR.0000000000001308","article-title":"Cardiovascular toxicity in patients treated for childhood cancer: a scientific statement from the American Heart Association","volume":"151","author":"Ryan","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.06.008_bib8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-pharmtox-030620-104842","article-title":"Preventing and treating anthracycline cardiotoxicity: new insights","volume":"61","author":"Sawicki","year":"2021","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41514-024-00135-7","article-title":"A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging","volume":"10","author":"Linders","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.jaccao.2026.06.008_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaccao.2026.06.008_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abn8017","article-title":"Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis","volume":"15","author":"Abe","year":"2022","journal-title":"Sci Signal"},{"key":"10.1016\/j.jaccao.2026.06.008_bib13","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/ijms23031912","article-title":"Mitochondrial-targeted therapy for doxorubicin-induced cardiotoxicity","volume":"23","author":"Wu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jaccao.2026.06.008_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.884174","article-title":"Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity","volume":"10","author":"Robinson","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib17","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1080\/14656566.2022.2124107","article-title":"Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients","volume":"23","author":"Stansfeld","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaccao.2026.06.008_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41569-025-01126-1","article-title":"Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment","volume":"22","author":"Fabiani","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1536\/ihj.23-302","article-title":"Single-cell transcriptomic analysis reveals myocardial fibrosis mechanism of doxorubicin-induced cardiotoxicity","volume":"65","author":"Huyan","year":"2024","journal-title":"Int Heart J"},{"key":"10.1016\/j.jaccao.2026.06.008_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fcvm.2020.00035","article-title":"Mechanisms of anthracycline-induced cardiotoxicity: is mitochondrial dysfunction the answer?","volume":"7","author":"Murabito","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102780","article-title":"Leucine zipper protein 1 prevents doxorubicin-induced cardiotoxicity in mice","volume":"64","author":"Fan","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cts.12857","article-title":"Epigenetic changes associated with anthracycline-induced cardiotoxicity","volume":"14","author":"Tantawy","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106215","article-title":"m(6)A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3","volume":"26","author":"Gao","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.jaccao.2026.06.008_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa035153","article-title":"The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia","volume":"351","author":"Lipshultz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008209","article-title":"Clinically translatable prevention of anthracycline cardiotoxicity by dexrazoxane is mediated by topoisomerase II beta and not metal chelation","volume":"14","author":"Jirkovsky","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jaccao.2026.06.008_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaccao.2019.08.003","article-title":"Efficacy of dexrazoxane in preventing anthracycline cardiotoxicity in breast cancer","volume":"1","author":"Macedo","year":"2019","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2352-4642(22)00239-5","article-title":"Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"6","author":"de Baat","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaccao.2026.06.008_bib29","article-title":"Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines","volume":"9","author":"de Baat","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaccao.2026.06.008_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10741-023-10328-z","article-title":"ACEI\/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis","volume":"28","author":"Gao","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jaccao.2026.06.008_bib31","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.06.008_bib32","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.06.008_bib33","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2018.02.049","article-title":"Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial","volume":"71","author":"Avila","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10549-024-07263-4","article-title":"Beta-blocker use and breast cancer outcomes: a meta-analysis","volume":"206","author":"Scott","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaccao.2026.06.008_bib35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41416-022-01891-7","article-title":"beta-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis","volume":"127","author":"Lofling","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaccao.2026.06.008_bib36","first-page":"11","article-title":"Mortality differences in coronary patients with breast cancer treated with trimetazidine dihydrochloride: potential therapeutic implications","volume":"12","author":"Cheng","year":"2025","journal-title":"Cardiooncology"},{"key":"10.1016\/j.jaccao.2026.06.008_bib37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7150\/jca.6888","article-title":"Use of ACE inhibitors and angiotensin receptor blockers and primary breast cancer outcomes","volume":"4","author":"Chae","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.jaccao.2026.06.008_bib38","first-page":"65","article-title":"Evaluating cardioprotective strategies for anthracycline-induced cardiotoxicity in breast cancer: insights from a systematic review and network meta-analysis","volume":"11","author":"Liu","year":"2025","journal-title":"Cardiooncology"},{"key":"10.1016\/j.jaccao.2026.06.008_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.947604","article-title":"Doxorubicin-induced cardiotoxicity is mediated by neutrophils through release of neutrophil elastase","volume":"12","author":"Bhagat","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib40","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s44161-024-00507-y","article-title":"Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction","volume":"3","author":"Bayer","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ehf2.12616","article-title":"Reactive fibrosis precedes doxorubicin-induced heart failure through sterile inflammation","volume":"7","author":"Tanaka","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jaccao.2026.06.008_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710146","article-title":"Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation","volume":"23","author":"Hsieh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib43","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","article-title":"Host and environmental factors influencing individual human cytokine responses","volume":"167","author":"Ter Horst","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jaccao.2026.06.008_bib44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMra2206346","article-title":"Humoral innate immunity and acute-phase proteins","volume":"388","author":"Mantovani","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib45","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1038\/s41467-023-38994-5","article-title":"Pathogen-specific innate immune response patterns are distinctly affected by genetic diversity","volume":"14","author":"Hader","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaccao.2026.06.008_bib46","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.immuni.2021.05.011","article-title":"Infectious and lifestyle modifiers of immunity and host resilience","volume":"54","author":"Bajpai","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaccao.2026.06.008_bib47","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41568-025-00858-z","article-title":"Ageing, immune fitness and cancer","volume":"25","author":"Dolan","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaccao.2026.06.008_bib48","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s43587-025-00898-y","article-title":"Restoring resident tissue macrophages to combat aging and cancer","volume":"5","author":"Park","year":"2025","journal-title":"Nat Aging"},{"key":"10.1016\/j.jaccao.2026.06.008_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41577-026-01269-3","article-title":"The ageing immune system as a driver of systemic ageing","volume":"26","author":"Jang","year":"2026","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1059173","article-title":"Immune system modulation in aging: molecular mechanisms and therapeutic targets","volume":"13","author":"Cisneros","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-05818-z","article-title":"Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications","volume":"15","author":"Cecerska-Heryc","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaccao.2026.06.008_bib52","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.immuni.2025.09.011","article-title":"Obesity, diabetes, and inflammation: pathophysiology and clinical implications","volume":"58","author":"Donath","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jaccao.2026.06.008_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","article-title":"Inflammation and resolution in obesity","volume":"21","author":"Sotak","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib54","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","article-title":"Sex-specific cardiovascular risks of cancer and its therapies","volume":"130","author":"Wilcox","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib55","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.3390\/jcm11175167","article-title":"Gender differences in diagnosis, prevention, and treatment of cardiotoxicity in cardio-oncology","volume":"11","author":"Simek","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.867873","article-title":"Genetics of anthracycline-associated cardiotoxicity","volume":"9","author":"Al-Otaibi","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00395-012-0267-3","article-title":"Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway","volume":"107","author":"Yao","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib58","article-title":"Doxorubicin exposure leads to cardiac fibroblast dysregulation and worsens fibrotic remodeling in the pathological heart","volume":"16","author":"Bagchi","year":"2026","journal-title":"J Mol Cell Cardiol Plus"},{"key":"10.1016\/j.jaccao.2026.06.008_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012338","article-title":"Targeting extracellular heat shock protein 70 ameliorates doxorubicin-induced heart failure through resolution of toll-like receptor 2-mediated myocardial inflammation","volume":"8","author":"Liu","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2026.06.008_bib60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12012-020-09576-4","article-title":"Involvement of ROS\/NLRP3 inflammasome signaling pathway in doxorubicin-induced cardiotoxicity","volume":"20","author":"Wei","year":"2020","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314649","article-title":"The innate immune system in cardiovascular diseases and its role in doxorubicin-induced cardiotoxicity","volume":"23","author":"Bhagat","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib62","series-title":"Inflammation in Chemotherapy-Induced Cardiotoxicity","author":"Hutchins","year":"2024"},{"key":"10.1016\/j.jaccao.2026.06.008_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030200","article-title":"Zymosan A improved doxorubicin-induced ventricular remodeling by evoking heightened cardiac inflammatory responses and healing in mice","volume":"12","author":"Xu","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2026.06.008_bib64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10557-025-07673-6","article-title":"Doxorubicin-induced cardiac remodeling: mechanisms and mitigation strategies","volume":"40","author":"Sun","year":"2026","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jaccao.2026.06.008_bib65","article-title":"Fibroblast-restricted inflammasome activation promotes atrial fibrillation and heart failure with diastolic dysfunction","volume":"10","author":"Li","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.124.071217","article-title":"Human single-nucleus RNA sequencing identifies CD47 as a therapeutic target for doxorubicin-induced cardiomyopathy","volume":"152","author":"Guo","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.06.008_bib67","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s44161-022-00094-w","article-title":"Neutrophils incite and macrophages avert electrical storm after myocardial infarction","volume":"1","author":"Grune","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yjmcc.2015.11.015","article-title":"Monocyte and macrophage contributions to cardiac remodeling","volume":"93","author":"Hulsmans","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib69","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib70","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1038\/s41467-024-52812-6","article-title":"Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy","volume":"15","author":"Kim","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaccao.2026.06.008_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113421","article-title":"Inflammatory markers S100A8\/A9 and metabolic alteration for evaluating signs of early phase toxicity of anticancer agent treatment","volume":"169","author":"Morikawa-Ichinose","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00395-023-01006-0","article-title":"Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy","volume":"118","author":"Nettersheim","year":"2023","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib73","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.3390\/ijms25179735","article-title":"Neutrophil biomarkers can predict cardiotoxicity of anthracyclines in breast cancer","volume":"25","author":"Todorova","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib74","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaccao.2024.10.010","article-title":"Shared mechanisms in cancer and cardiovascular disease: S100A8\/9 and the NLRP3 inflammasome: JACC: CardioOncology state-of-the-art review","volume":"7","author":"Van Linthout","year":"2025","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib75","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/s43018-025-00988-1","article-title":"Cardiomyocyte-localized CCDC25 senses NET DNA to promote doxorubicin cardiotoxicity by activating autophagic flux","volume":"6","author":"Nie","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jaccao.2026.06.008_bib76","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00018-024-05169-4","article-title":"Neutrophil extracellular traps mediate cardiomyocyte ferroptosis via the Hippo-Yap pathway to exacerbate doxorubicin-induced cardiotoxicity","volume":"81","author":"Zhao","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib77","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003126","article-title":"Intercellular adhesion molecule 1 regulates left ventricular leukocyte infiltration, cardiac remodeling, and function in pressure overload-induced heart failure","volume":"5","author":"Salvador","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2026.06.008_bib78","doi-asserted-by":"crossref","first-page":"H1301","DOI":"10.1152\/ajpheart.00566.2019","article-title":"Pharmacological blockage of ICAM-1 improves angiotensin II-induced cardiac remodeling by inhibiting adhesion of LFA-1(+) monocytes","volume":"317","author":"Lin","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115469","article-title":"IL-27p28 knockout aggravates doxorubicin-induced cardiotoxicity by regulating macrophage polarization","volume":"210","author":"Feng","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib81","article-title":"SLAMF7 restrains pro-inflammatory macrophage activation to counteract doxorubicin-induced cardiotoxicity","volume":"10","author":"Liu","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib82","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jacbts.2024.06.003","article-title":"Emerging role of macrophage-fibroblast interactions in cardiac homeostasis and remodeling","volume":"10","author":"Zhang","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib83","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/CIRCRESAHA.119.316428","article-title":"Self-maintenance of cardiac resident reparative macrophages attenuates doxorubicin-induced cardiomyopathy through the SR-A1-c-Myc axis","volume":"127","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib84","article-title":"TRPA1 deficiency aggravates dilated cardiomyopathy by promoting S100A8 expression to induce M1 macrophage polarization in rats","volume":"37","author":"Wang","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.jaccao.2026.06.008_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5179468","article-title":"Inhibition of TRPA1 attenuates doxorubicin-induced acute cardiotoxicity by suppressing oxidative stress, the inflammatory response, and endoplasmic reticulum stress","volume":"2018","author":"Wang","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jaccao.2026.06.008_bib86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jlb.58.2.209","article-title":"Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation","volume":"58","author":"Yellin","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib87","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1161\/CIRCRESAHA.122.321587","article-title":"Critical role of the cGAS-STING pathway in doxorubicin-induced cardiotoxicity","volume":"132","author":"Luo","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-022-00631-0","article-title":"GAS-STING signaling plays an essential pathogenetic role in doxorubicin-induced cardiotoxicity","volume":"24","author":"Xiao","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib89","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaccao.2023.03.012","article-title":"Evaluation of senescence and its prevention in doxorubicin-induced cardiotoxicity using dynamic engineered heart tissues","volume":"5","author":"Linders","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib90","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacbts.2023.02.014","article-title":"IFN-gamma-STAT1-ERK pathway mediates protective effects of invariant natural killer T cells against doxorubicin-induced cardiomyocyte death","volume":"8","author":"Sada","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib91","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.123.323346","article-title":"Exercise inhibits doxorubicin-induced cardiotoxicity via regulating B cells","volume":"134","author":"Wang","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib92","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s42003-024-07315-x","article-title":"Cross-species single-cell RNA-seq analysis reveals disparate and conserved cardiac and extracardiac inflammatory responses upon heart injury","volume":"7","author":"Cortada","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib93","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvinukova","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2026.06.008_bib94","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jaccao.2025.06.008","article-title":"Cancer-related immune therapies: bidirectional implications from cardiotoxicity to emerging cardiovascular therapeutics: JACC CardioOncology state-of-the-art review","volume":"7","author":"Miteva","year":"2025","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib95","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib96","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/cvr\/cvaf098","article-title":"Targeting CD8+ T cells in cardiovascular diseases: current options and therapeutic perspectives","volume":"121","author":"Al-Rifai","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib97","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib98","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157788","article-title":"Targeting IL-1beta as an immunopreventive and therapeutic modality for K-ras-mutant lung cancer","volume":"7","author":"Yuan","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaccao.2026.06.008_bib99","article-title":"Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib100","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jacc.2013.11.023","article-title":"In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing","volume":"63","author":"Courties","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-010-9180-8","article-title":"TNFalpha in myocardial ischemia\/reperfusion, remodeling and heart failure","volume":"16","author":"Kleinbongard","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jaccao.2026.06.008_bib102","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib103","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib104","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tem.2024.02.003","article-title":"Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors","volume":"35","author":"Mashayekhi","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jaccao.2026.06.008_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116759","article-title":"Empagliflozin attenuates doxorubicin-induced cardiotoxicity by inhibiting the JNK signaling pathway","volume":"176","author":"Chang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaccao.2026.06.008_bib106","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10741-024-10450-6","article-title":"GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction","volume":"30","author":"Bonfioli","year":"2025","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jaccao.2026.06.008_bib107","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.120.045888","article-title":"Glucagon-like peptide 1 receptor agonists and heart failure","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.06.008_bib108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jaccao.2026.06.008_bib109","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/cvr\/cvaa181","article-title":"Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity","volume":"117","author":"Galan-Arriola","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib110","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1161\/ATVBAHA.121.316388","article-title":"Remote ischemic preconditioning protects against endothelial dysfunction in a human model of systemic inflammation: a randomized clinical trial","volume":"41","author":"Orlandi","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib111","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00395-021-00852-0","article-title":"Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response","volume":"116","author":"Pearce","year":"2021","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib112","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.3390\/ijms26094071","article-title":"Interleukin-6 in anthracycline-related cardiac dysfunction: a comparison with myeloperoxidase and TNF-alpha","volume":"26","author":"Borowiec","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib113","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.06.008_bib114","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1038\/s41598-017-02627-x","article-title":"Early detection and serial monitoring of anthracycline-induced cardiotoxicity using T1-mapping cardiac magnetic resonance imaging: an animal study","volume":"7","author":"Hong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaccao.2026.06.008_bib115","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cancers15030986","article-title":"Global longitudinal strain in cardio-oncology: a review","volume":"15","author":"Slawinski","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaccao.2026.06.008_bib116","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/eurheartj\/ehu188","article-title":"Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction","volume":"35","author":"Rubini Gimenez","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2026.06.008_bib117","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2018.01.070","article-title":"Elevated cardiac troponin T in patients with skeletal myopathies","volume":"71","author":"Schmid","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib118","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/CIRCULATIONAHA.123.062405","article-title":"Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis","volume":"148","author":"Lehmann","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.06.008_bib119","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.015782","article-title":"Impaired cardiac and skeletal muscle energetics following anthracycline therapy for breast cancer","volume":"16","author":"Gamble","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2026.06.008_bib120","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.124.323892","article-title":"Cardiac fibroblastic niches in homeostasis and inflammation","volume":"134","author":"Cadosch","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib121","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","article-title":"Targeting immune-fibroblast cell communication in heart failure","volume":"635","author":"Amrute","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2026.06.008_bib122","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/ejhf.3636","volume":"27","author":"Ghigo","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2026.06.008_bib123","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13287-024-03814-0","article-title":"Immune response caused by M1 macrophages elicits atrial fibrillation-like phenotypes in coculture model with isogenic hiPSC-derived cardiomyocytes","volume":"15","author":"Hutschalik","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jaccao.2026.06.008_bib124","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.stem.2025.09.011","article-title":"Human heart-macrophage assembloids mimic immune-cardiac interactions and enable arrhythmia disease modeling","volume":"32","author":"O'Hern","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jaccao.2026.06.008_bib125","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.125.326823","article-title":"Human multi-organoid platform to model immune dynamics in cardiac injury and disease","volume":"137","author":"Reyat","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tcm.2021.02.009","article-title":"Translational insights from single-cell technologies across the cardiovascular disease continuum","volume":"32","author":"van Blokland","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib127","article-title":"Effects of immunogenic cell death-inducing chemotherapeutics on the immune cell activation and tertiary lymphoid structure formation in melanoma","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib128","article-title":"CDK2 inhibition sensitizes anthracycline-induced immunogenic cell death and enhances the efficacy of anti-PD-1 therapy","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib129","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s43018-023-00570-7","article-title":"Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-gamma is a major determinant of CD4(+) CAR T-cell antitumor activity","volume":"4","author":"Boulch","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jaccao.2026.06.008_bib130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41419-025-08021-0","article-title":"Combined IFN-gamma and TNF-alpha treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing","volume":"16","author":"Barberini","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaccao.2026.06.008_bib131","article-title":"Dual immunotherapy alternating with anti-PD-1 antibody plus liposomal doxorubicin show good efficacy in prostate epithelioid hemangioendothelioma: a case report","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib132","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1158\/1078-0432.CCR-25-0618","article-title":"A single-arm phase 2 trial of doxorubicin plus zalifrelimab (Anti-CTLA-4 antibody) and balstilimab (Anti-PD-1 antibody) in advanced\/metastatic soft tissue sarcomas","volume":"31","author":"Wilky","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaccao.2026.06.008_bib133","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/s41467-025-57965-6","article-title":"A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaccao.2026.06.008_bib134","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/neuonc\/noae135","article-title":"Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: a novel combinatorial immunotherapy regimen for gliomas","volume":"26","author":"Kim","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib135","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.biocel.2012.06.010","article-title":"The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase","volume":"44","author":"Bhinge","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib136","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00689270","article-title":"Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes","volume":"27","author":"Bally","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaccao.2026.06.008_bib137","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41525-021-00199-4","article-title":"Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity","volume":"6","author":"Scott","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jaccao.2026.06.008_bib138","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/cas.14446","article-title":"Genome-wide association study of genetic variants related to anthracycline-induced cardiotoxicity in early breast cancer","volume":"111","author":"Park","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jaccao.2026.06.008_bib139","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33480","article-title":"Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes","volume":"7","author":"Knowles","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jaccao.2026.06.008_bib140","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1038\/s41467-022-34917-y","article-title":"A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes","volume":"13","author":"Wu","year":"2022","journal-title":"Nat Commun"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326002759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326002759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:43:35Z","timestamp":1792712615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087326002759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666087326002759"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.06.008","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune Pathways in Doxorubicin Cardiotoxicity: A Cardio-Immunology Perspective","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}